Skip to Main Content
Skip Nav Destination






(toe poe TEE kan)

Brand Names: US

  • Hycamtin

Therapeutic Category

  • Antineoplastic Agent, Camptothecin
  • Antineoplastic Agent, Topoisomerase Inhibitor

Medication Safety Issues

Sound-alike/look-alike issues:

Hycamtin may be confused with Mycamine

Topotecan may be confused with irinotecan

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.

Other safety concerns:

Topotecan overdoses have been reported; potential causes include omission of the leading zero and missing the decimal point when prescribing, preparing, and administering. Recommended intravenous doses should generally not exceed 4 mg; verify dose prior to administration.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal